Tuberculosis (TB) remains a major health problem worldwide. The infectious agent,
Mycobacterium tuberculosis, has a unique ability to survive within the host, alternating …

Abstract The Pathogen Box is a 400‐strong collection of drug‐like compounds, selected for
their potential against several of the world's most important neglected tropical diseases …

Tuberculosis remains one of the deadliest infectious diseases in the world, and the
increased number of multidrug-resistant and extremely drug-resistant strains is a significant …

Tuberculosis (TB) still continues to be a major killer disease worldwide. Unlike other bacteria
Mycobacterium tuberculosis (Mtb) has the ability to become dormant within the host and to …

Mycobacterium tuberculosis is the etiological agent of tuberculosis (TB), an infectious
disease which results in approximately 10 million incident cases and 1.4 million deaths …

Tuberculosis is still an urgent global health problem, mainly due to the spread of multi-drug
resistant M. tuberculosis strains, which lead to the need of new more efficient drugs. A …

Tuberculosis (TB), an airborne infectious disease mainly caused by Mycobacterium
tuberculosis (Mtb), remains a leading cause of human morbidity and mortality worldwide …

The dormant and resistant form of Mycobacterium tuberculosis presents a challenge in
developing new anti-tubercular drugs. Herein, we report the synthesis and evaluation of …

Mycobacterium tuberculosis, the etiological agent of the infectious disease tuberculosis, kills
approximately 1.5 million people annually, while the spread of multidrug-resistant strains is …

Despite decades of dedicated research, there remains a dire need for new drugs against
tuberculosis (TB). Current therapies are generations old and problematic. Resistance to …